FICO:NYSEFair Isaac Corporation Analysis
Data as of 2026-03-10 - not real-time
$1,409.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Fair Isaac Corporation (FICO) is trading at $1,409.5, well above its DCF‑derived fair value of $532, indicating a substantial premium. The stock sits below its 20‑day ($1,378.9), 50‑day ($1,485.8) and 200‑day ($1,598.5) moving averages, and the RSI of 48 suggests a neutral momentum with no clear overbought signal. However, the MACD histogram is positive (+19.2) and the MACD line sits above the signal line, hinting at a short‑term bullish tilt despite an overall bearish trend direction and decreasing volume. Support sits near $1,193.1 and resistance around $1,494, leaving limited upside on the near term.
The fundamentals paint a more optimistic picture: revenue grew 16% YoY to $2.06 bn, operating margin is a robust 45.7%, and free cash flow exceeds $573 m. Analysts are largely positive, with a consensus “Buy” rating and a target median price of $2,010, while the company announced a $1.5 bn share‑repurchase program. The market’s “Extreme Greed” sentiment (Fear‑Greed Index 77) and a 38.8% upside potential relative to the current price add further bullish color, though the high P/E of 52 versus an industry average of 36.9 signals notable valuation risk.
The fundamentals paint a more optimistic picture: revenue grew 16% YoY to $2.06 bn, operating margin is a robust 45.7%, and free cash flow exceeds $573 m. Analysts are largely positive, with a consensus “Buy” rating and a target median price of $2,010, while the company announced a $1.5 bn share‑repurchase program. The market’s “Extreme Greed” sentiment (Fear‑Greed Index 77) and a 38.8% upside potential relative to the current price add further bullish color, though the high P/E of 52 versus an industry average of 36.9 signals notable valuation risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages indicating bearish bias
- Decreasing volume trend reducing short‑term liquidity
- Positive MACD histogram suggesting limited upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high operating margins
- $1.5 bn share‑repurchase authorization supporting price
- Analyst consensus “Buy” with median target above current price
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable cash flow generation and low debt‑to‑equity profile
- Leadership in analytics and credit‑scoring market with global reach
- Growth‑oriented business model despite current valuation premium
Key Metrics & Analysis
Financial Health
Revenue Growth16.40%
Profit Margin31.89%
P/E Ratio52.3
ROA34.76%
P/B Ratio-18.5
Op. Cash Flow$758.9M
Free Cash Flow$573.2M
Industry P/E36.9
Technical Analysis
TrendBearish
RSI48.0
Support$1,193.10
Resistance$1,494.00
MA 20$1,378.87
MA 50$1,485.82
MA 200$1,598.47
MACDBullish
VolumeDecreasing
Fear & Greed Index77.13
Valuation
Fair Value$532.09
Target Price$1,955.76
Upside/Downside38.76%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.94
Volatility48.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.